Author:
Schmidt Megan E.,Varga Steven M.
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference116 articles.
1. American Academy of Pediatrics Committee on Infectious, D. and American Academy of Pediatrics Bronchiolitis Guidelines, C. 2014. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134, 415–420.
2. American Academy of Pediatrics Subcommittee on, D. and Management of, B. 2006. Diagnosis and management of bronchiolitis. Pediatrics 118, 1774–1793.
3. Arnold, R., Konig, B., Werchau, H., and Konig, W. 2004. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology 330, 384–397.
4. Beeler, J.A. and van Wyke Coelingh, K. 1989. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J. Virol. 63, 2941–2950.
5. Bembridge, G.P., Garcia-Beato, R., Lopez, J.A., Melero, J.A., and Taylor, G. 1998. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J. Immunol. 161, 2473–2480.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献